Color Vision Defects: Clinical Trials

62 trials for Color Vision Defects, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

35 completed, 9 recruiting, 5 unknown, 4 active not recruiting. 26 Not applicable, 11 Phase 2, 9 Phase 1, 4 Early Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable26Completed 18, Active not recruiting 3, Recruiting 2, Unknown 2, Terminated 1
Phase 211Completed 5, Recruiting 2, Unknown 2, Active not recruiting 1, Suspended 1
Phase 19Completed 5, Unknown 2, Active not recruiting 1, Terminated 1
Early Phase 14Completed 1, Not yet recruiting 1, Recruiting 1, Suspended 1
Phase 33Recruiting 2, Terminated 1
Phase 42Completed 2

Follow Color Vision Defects: new trials by email Literature Review of Color Vision Defects trials Research Report on Color Vision Defects

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Topical CBD Scar Outcomes Study
Group 1 cannabidiol (CBD) with silicone ointment, Group 2 silicone patch - Forehead; Wound
Early Phase 1Not yet recruitingUniversity of Oklahoma222026-09-012026-04-01
Naturally Produced Cannabinoids for Neuroprotection From Concussion
Broad spectrum cannabinoid formulation, Placebo gel capsule - Healthy
Phase 2RecruitingUniversity of Regina602026-06-012026-07-21
Analysis of the Therapeutic and Clinical Profile of Cannabinoid Treatments: A Real-World Study
Participants are followed while using cannabis-based products (such as CBD or THC oils, extracts, or isolates) as prescribed by their own physicians for therapeutic purposes. - Chronic Pain, Depression Disorders
Enrolling by invitationSanta Catarina Federal University3842026-03-012026-03-30
Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements
Transcranial Magnetic Stimulation (TMS), Electroencephalography (EEG), Eye-Tracking - Visual Snow Syndrome, Color Blindness
Not applicableRecruitingSkolkovo Institute of Science and Technology502025-09-102025-08-07
Re-use of Ambu aScope During Exploration of the Common Bile Duct for Stones in Low-Resource Settings- a Retrospective Study
Ambu aScope for visualization of biliary tree during exploration of CBD for stone - CBD Stone
CompletedB.P. Koirala Institute of Health Sciences752025-08-132025-12-16
Natural History Study of Inherited Retinal Diseases
Retinal Dystrophies, Color Vision Defects
RecruitingZhongmou Therapeutics2002025-07-202025-12-10
RCT of CBT Based C.A.T Project for Pakistani Adolescents With Anxiety Disorders.
CBT Based C.A.T Project- Intervention for Anxious Adolescents. - Anxiety Disorder of Adolescence
Not applicableActive not recruitingNational University of Science and Technology502025-07-072025-10-02
Imaging Studies in Corticobasal Syndrome
C-11 ER176 Radiotracer, C-11 PiB, AV1451 Tau - Cortico Basal Degeneration, Corticobasal Syndrome
RecruitingJennifer Whitwell802025-06-252026-07-14
PBA Use for Treatment of ATF6-/- Patients
PBA - ACHROMATOPSIA 7, Achromatopsia
Early Phase 1SuspendedColumbia University22025-04-082026-09-11
Vulvodynia Intervention: the Effect of Multimodal Treatment for Provoked Vulvodynia
Vulvodynia Intervention: a multimodal treatment for provoked vulvodynia - Vulvodynia (Chronic Vulvar Pain)
Not applicableActive not recruitingKarlstad University502025-03-112026-08-12
Delivery Format of Cognitive Behavioral Therapy Materials on Engagement and Outcomes: AI-Enabled App vs PDF Workbook
Limbic Care, Digital Workbook - Mental Health Issue
Not applicableCompletedLimbic Limited5402024-06-052024-12-06
Treating Suicidality Remotely
Brief Cognitive Behavioral Therapy for Suicide Prevention, Living under control - Suicide Attempt
Not applicableRecruiting113 Suicide Prevention3642024-05-072024-05-20
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical ProTractX3 TTS DCB, Control - Bowel; Stricture
Phase 3RecruitingGIE Medical1712023-11-012025-06-25
Psychological Intervention Using Smartphone Technology to Alleviate Malignant Pain
Cognitive Behavioral Therapy for pain - Cancer Pain, Opioid Use
Not applicableCompletedUniversity of Oklahoma522023-05-042025-11-04
Alcohol Use Disorder and Cannabidiol
Cannabidiol, Placebo - Alcohol Use Disorder
Phase 2 / Phase 3RecruitingUniversity of Colorado, Denver1802023-04-302026-06-15
This Research Study Examines the Effects of Cannabidiol-infused Candy on Reducing the Bacteria Causing Tooth Decay, When Comparing it to a Sugar Free Candy on Adults.
CBD infused candy, Sugar free Candy - Tooth Decay
Not applicableCompletedWest Coast University302023-01-272024-03-08
MIRAGE Study: Clinical Outcomes of the Mamba Sirolimus-Eluting PTCA Balloon
Mamba Sirolimus-Eluting PTCA Balloon, Percutaneous Coronary Angioplasty with Sirolimus-Coated Balloon - Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Phase 4CompletedFrisch Medical Device Private Limited3602023-01-112026-03-11
Impact of Color Correcting Lenses on Color Vision Deficiency
Experimental Group 1: Color Correcting Lenses, Placebo Group 1: Placebo Lenses, Placebo Group 1 Crosses over to become Experimental Group 2: Color Correcting Lenses - Color Blindness, Color Vision Defects
Not applicableCompletedUniversity of the Incarnate Word352022-07-282024-04-03
Blended Treatment för PTSD Feasibility Study
Trauma-focused cognitive behavioural therapy via a digital support - Acceptability of Health Care
Not applicableCompletedKarolinska Institutet172021-05-202024-03-07
Virtual Cognitive Behavioural Therapy for Psychosis
Virtual Cognitive Behavioural Therapy for Psychosis - Psychotic Disorders, Schizophrenia
Not applicableCompletedUniversity of Toronto702021-02-012025-07-29

Showing 20 of 62. Sign in to see all of them.

Narrower conditions

Marijuana Abuse (4)  ·  Chronic Pain (3)  ·  Corticobasal Degeneration (3)  ·  Psychotic Disorders (3)  ·  Achromatopsia 3 (2)  ·  Anxiety Disorders (2)  ·  Depression (2)  ·  Eye Diseases (2)  ·  Macular Degeneration (2)  ·  Night blindness, congenital stationary (2)  ·  Primary Progressive Nonfluent Aphasia (2)  ·  Retinitis Pigmentosa (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Suicide (2)

Broader conditions

Pathological Conditions, Signs and Symptoms (62)  ·  Cone Dystrophy (61)  ·  Eye Diseases, Hereditary (61)  ·  Nervous System Diseases (61)  ·  Neurologic Manifestations (61)  ·  Sensation Disorders (61)  ·  Signs and Symptoms (61)  ·  Eye Diseases (60)  ·  Vision Disorders (60)  ·  Mental Disorders (17)  ·  Central Nervous System Diseases (9)  ·  Behavior (8)  ·  Brain Diseases (8)  ·  Pathologic Processes (6)  ·  Neurodegenerative Diseases (5)

Interventions

Cognitive Behavioral Therapy (6)  ·  Cannabidiol (2)  ·  Medical Marijuana (2)  ·  Psychosocial Intervention (2)  ·  Case-Control Studies (1)  ·  Color Vision (1)  ·  Dronabinol (1)  ·  Electroencephalography (1)  ·  Eye-Tracking Technology (1)  ·  Hypnosis (1)  ·  Immunization, Secondary (1)  ·  Psychotherapy (1)  ·  Psychotherapy, Group (1)  ·  TPI-287 (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

MeiraGTx UK II Ltd (4)  ·  Beacon Therapeutics (3)  ·  Pakistan Institute of Living and Learning (3)  ·  University Hospital Tuebingen (3)  ·  University of California, San Francisco (3)  ·  Karolinska Institutet (2)  ·  University of Colorado, Denver (2)  ·  University of Oklahoma (2)  ·  113 Suicide Prevention (1)  ·  Aalen University (1)  ·  Alaska Blind Child Discovery (1)  ·  Anglia Ruskin University (1)  ·  B.P. Koirala Institute of Health Sciences (1)  ·  CENTOGENE GmbH Rostock (1)  ·  Central Institute of Mental Health, Mannheim (1)

Countries

United States (27)  ·  United Kingdom (8)  ·  Germany (6)  ·  Canada (5)  ·  Pakistan (5)  ·  Sweden (4)  ·  Malaysia (2)  ·  Netherlands (2)  ·  Albania (1)  ·  Brazil (1)  ·  Burma (1)  ·  China (1)  ·  Denmark (1)  ·  Egypt (1)  ·  Georgia (1)

Top investigators

Farooq Naeem, MRCPsych (3)  ·  Imran Chaudhry, MD (3)  ·  Munir Hamirani, FCPS (3)  ·  Nusrat Husain, MD (3)  ·  Adam Boxer, MD, PhD (2)  ·  David Jacobs, MD, MBA (2)  ·  Adam L Boxer, MD, PhD (1)  ·  Ajmal Kazmi (1)  ·  Andreas Michaelides, PhD (1)  ·  Anil Batra, Prof. (1)  ·  Annum Tanweer (1)  ·  Batool Fatima (1)  ·  Bhavin Oza (1)  ·  Danielle Andrade, MD (1)

Results publications

PMID 16353397, PMID 23287811, PMID 24676964, PMID 25205868, PMID 25856136, PMID 26399571, PMID 26812041, PMID 27479814, PMID 28803030, PMID 29095725, PMID 29207980, PMID 29977501, PMID 30194931, PMID 31710340, PMID 32352493, PMID 32930011, PMID 33827960, PMID 33884617, PMID 34006508, PMID 34417217, PMID 35492244, PMID 35790423, PMID 36154908, PMID 37172884, PMID 38476396, PMID 38684918, PMID 39301223, PMID 41540194, PMID 41854598, PMID 42015291, PMID 42036783, PMID 42812108

NIH funding

2016 (2), R24EY022023 (2), 2014 (1), 2023 (1), R01AA029606 (1), R01AG087140 (1), R21CA263838 (1), T35EY032441 (1), U54NS092089 (1)